TD Waterhouse Canada’s VanEck Pharmaceutical ETF PPH Stock Holding History

TD Waterhouse Canada’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.8K	Buy	230 +130	+130%	+$13.5K	﹤0.01%	1604
2026 Q1	$10.4K	Hold	100	–	–	﹤0.01%	1744
2025 Q4	$10.3K	Sell	100 -70	-41%	-$6.81K	﹤0.01%	1537
2025 Q3	$16.1K	Hold	170	–	–	﹤0.01%	1439
2025 Q2	$15K	Hold	170	–	–	﹤0.01%	1366
2025 Q1	$15K	Hold	170	–	–	﹤0.01%	1322
2024 Q4	$14.7K	Hold	170	–	–	﹤0.01%	1340
2024 Q3	$16K	Hold	170	–	–	﹤0.01%	1270
2024 Q2	$15.6K	Hold	170	–	–	﹤0.01%	1270
2024 Q1	$18.3K	Sell	170 -270	-61%	-$23.6K	﹤0.01%	1250
2023 Q4	$36.9K	Sell	440 -82	-16%	-$6.43K	﹤0.01%	1010
2023 Q3	$41.3K	Sell	522 -19,366	-97%	-$1.56M	﹤0.01%	962
2023 Q2	$1.57M	Buy	+19,888	New	+$1.56M	0.02%	354

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

TD Waterhouse Canada's PPH Position: Q2 2026 in Review

TD Waterhouse Canada increased its VanEck Pharmaceutical ETF (PPH) stake by 130% in Q2 2026, buying an estimated $13.5K and bringing the position to 230 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

TD Waterhouse Canada first reported a position in PPH in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.57M in Q2 2023. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

TD Waterhouse Canada held 230 shares of VanEck Pharmaceutical ETF worth $24.8K as of Q2 2026.
TD Waterhouse Canada bought 130 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $13.5K.
VanEck Pharmaceutical ETF made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1604 holding.
TD Waterhouse Canada first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and has held it in 13 quarters since.
TD Waterhouse Canada's VanEck Pharmaceutical ETF position peaked at $1.57M in Q2 2023.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.